Oncology and Palliative Care Integration Model: A Cost Analysis Study in a Brazilian Hospital Setting
American Journal of Hospice and Palliative Medicine® · 2024
DOI: 10.1177/10499091241232401 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hospice and Palliative Medicine®, 2024. Verfasst von Tânia V V Guimarães und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Palliative Care, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Instituto do Câncer do Estado de São Paulo.
Themen: Palliativpflege
Abstract (Originalsprache)
Background
In 2019, the São Paulo State Cancer Institute (ICESP) implemented a novel model integrating Oncology with Palliative Care specialists. We evaluated the impact of this model on healthcare resource utilization and costs.
Methods
We analyzed data from all patients who passed away in February (1 month prior to implementation) and November (8 months after model implementation group) at ICESP, Brazil. Healthcare utilization data, including emergency department visits, hospital and intensive care unit admissions, chemotherapy, and radiotherapy use, were retrieved from Electronic Medical Records. Unit cost values were obtained from the administrative database.
Results
A total of 198 patients who died in February and 196 in November were included in the analysis. Groups exhibited similarities in sex, age, ECOG, cancer type, previous outpatient palliative care consultations, and place of death (ward: 56.6% pre-intervention, 50% post-intervention). The mean cost per patient was US$13,226.29 pre-intervention and US$11,445.82 post-intervention ( P = .007). Statistically significant differences were noted in days hospitalized in the surgical ward (227 vs 115), emergency department visits (233 vs 45), chemotherapy sessions (140 vs 26), and radiotherapy sessions (146 vs 10). Excluding outpatient treatments, the total costs for chemotherapy and radiotherapy in the last 30 days of life were US$16,924.45 pre-intervention and US$7851.65 post-intervention. Reductions were more pronounced in patients with ECOG 3-4 ( P = .039).
Conclusion
Our data suggests that the integration model was associated with a reduction in potentially inappropriate treatments during the last month of life, leading to decreased healthcare utilization and costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
- Departamento de Medicina Preventiva, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
ORCID-Profile: Alessandro G Campolina, Maria D P Estevez Diz
Förderung
- Instituto do Câncer do Estado de São Paulo
Zitieren
APA
Guimarães, T. V. V., Campolina, A. G., Rozman, L. M., Chiba, T., de Soárez, P. C., & Estevez Diz, M. D. P. (2024). Oncology and Palliative Care Integration Model: A Cost Analysis Study in a Brazilian Hospital Setting. American Journal of Hospice and Palliative Medicine®. https://doi.org/10.1177/10499091241232401
Vancouver
Guimarães TVV, Campolina AG, Rozman LM, Chiba T, de Soárez PC, Estevez Diz MDP. Oncology and Palliative Care Integration Model: A Cost Analysis Study in a Brazilian Hospital Setting. American Journal of Hospice and Palliative Medicine®. 2024. doi:10.1177/10499091241232401
BibTeX
@article{Guimares2024,
author = {Guimarães, Tânia V V and Campolina, Alessandro G and Rozman, Luciana M and Chiba, Toshio and de Soárez, Patrícia C and Estevez Diz, Maria D P},
title = {Oncology and Palliative Care Integration Model: A Cost Analysis Study in a Brazilian Hospital Setting},
journal = {American Journal of Hospice and Palliative Medicine®},
year = {2024},
doi = {10.1177/10499091241232401}
}
EUVIMED